Richard Cappetta, President and CEO of MicroVention, Inc., said: "The HEAT trial is intended to provide evidence that our second-generation hydrogel coil technologies provide superior long-term ...

The LVIS® and LVIS® Jr. stents are the first stents PMA approved for stent-assisted coil embolization An intracranial aneurysm is a bulging, weak area in the wall of an artery that supplies blood to ...

MIAMI & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation ...

Please provide your email address to receive an email when new articles are posted on . Patients with intracranial aneurysms who underwent embolization with second-generation hydrogel-coated coils ...

May 20, 2011 — For endovascular treatment of intracranial aneurysms, hydrogel-coated coils are safe, with no evidence of worse clinical outcomes compared with bare platinum coils, and are associated ...

MicroVention Inc., an Aliso Viejo-based startup medical device maker, has nabbed $10 million in an extension of its fourth round of venture funding. The new investment brings MicroVention’s total ...

(MENAFN- AETOSWire) (BUSINESS WIRE )-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating ...

US-based neuroendovascular device company MicroVention has announced a court settlement against three former members of staff accused of misappropriating trade secrets about the company’s embolic ...

The Global Neuroendovascular Coil Market is expected to grow at 5.2% CAGR from 2025 to 2032. The Latest detailed study on the global Neuroendovascular Coil Market 2025-2032, Outlook is performed by ...